Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines

por Vanhoefer, U, Müller, M R, Hilger, R A, Lindtner, B, Klaassen, U, Schleucher, N, Rustum, Y M, Seeber, S
Publicado 1999

Oxaliplatin-DNA adduct formation in white blood cells of cancer patients

por Pieck, A C, Drescher, A, Wiesmann, K G, Messerschmidt, J, Weber, G, Strumberg, D, Hilger, R A, Scheulen, M E, Jaehde, U
Publicado 2008

P1262: EZH2 INHIBITORS MEDIATE PLATINUM RESISTANCE BY ENHANCED EFFLUX

por Groß, E., Hilger, R.-A., Wehde, J., Schümann, F. L., Rohde, C., Willscher, E., Lützkendorf, J., Müller, L. P., Edemir, B., Müller, T., Binder, M., Posern, G., Weber, T.
Publicado 2022

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors

por Bauer, S, Hilger, R A, Mühlenberg, T, Grabellus, F, Nagarajah, J, Hoiczyk, M, Reichardt, A, Ahrens, M, Reichardt, P, Grunewald, S, Scheulen, M E, Pustowka, A, Bock, E, Schuler, M, Pink, D
Publicado 2014